bioRxivImmunologyPreprint
FGFR1-phosphate sensing and crystal-induced gasdermin D signaling in neutrophils drive vascular calcification in CKD
Atsuko Miyoshi, Daigo NakazawaiD, Tetsuo Shimizu, Kanako Watanabe‐KusunokiiD, Fumihiko HattandaiD, Saori Nishio, Satoka Shiratori‐Aso, Y UedaiD, Mizuki Kimura, Takuro KawamuraiD, Shun Takenaka, Masatoshi KandaiD, Sakiko MasudaiD, Yuka NishibataiD, Utano Tomaru, Yasushige ShinguiD, Satoru WakasaiD, Akihiro IshizuiD, Tatsuya AtsumiiD
Abstract
Chronic kidney disease (CKD) confers disproportionate cardiovascular risk. In non-dialysis CKD, calcification accumulates primarily within the intimal layer. Clinical studies indicate that intimal calcification correlates with hyperphosphatemia, yet the cellular and molecular pathways remain unclear. Given evidence that osteocytes sense phosphate via fibroblast growth factor receptor 1 (FGFR1), we hypothesized that FGFR1-expressing vascular immune cells, especially neutrophils, act as mediators linking high phosphate to plaque mineralization. In vitro, phosphate triggered FGFR1-dependent signaling in human and murine neutrophils, inducing neutrophil extracellular traps (NETs). Activated neutrophils promoted the depletion of Fetuin-A, a major inhibitor of calcium-phosphate complexation, creating a milieu permissive to mineral nucleation. Newly formed calcium-phosphate particles amplified NETs through gasdermin D (GSDMD), establishing a feed-forward loop that enhanced mineralization and endothelial injury in co-culture assays. Human arteriosclerotic plaques from CKD patients showed NETs markers co-localizing with calcified deposits. In vivo, pharmacological FGFR inhibition attenuated arterial intimal calcification and suppressed NET formation in CKD mice. These findings identify phosphate sensing via neutrophil FGFR1 and subsequent crystal-induced GSDMD signaling as drivers of intimal vascular calcification in CKD. Targeting phosphate-sensing pathways, NET formation, and neutrophil-driven mineralization may mitigate vascular calcification and reduce cardiovascular risk in CKD.
- organism: human
- organism: mouse
- assay: proteomics
- assay: imaging
- research focus: cell signaling & trafficking
- research focus: development & morphogenesis
- research focus: differential expression
- approach: experimental assay
- approach: wet-lab / biochemical assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The role of Platelet-derived growth factor (PDGF) in uremic vascular calcification.
Burcu Yesilyurt Öztürk, Li Zhang, … Peter Boor·bioRxiv·Jul 9, 2025
- Vascular calcification has a role in acute non-renal phosphate clearance
M. E. Turner, A. P. Lansing, … M. A. Adams·bioRxiv·Jul 29, 2020
- Loss of PKCα increases arterial medial calcification in a uremic mouse model of chronic kidney disease
S. J. Borland, C. Facchi, … A. E. Canfield·bioRxiv·May 20, 2020
- Activation of the IKK2-NFκB pathway in VSMCs inhibits calcified vascular stiffness in CKD by reducing the secretion of calcifying extracellular vesicles.
S. Miyazaki, M. Masuda, … M. Miyazaki·bioRxiv·Jul 11, 2023
- Hypoxia-inducible factor (HIF) activation promotes osteogenic transition of valve interstitial cells and accelerates heart valve calcification in chronic kidney disease (CKD)
D. M. Csiki, H. Ababneh, … V. Jeney·bioRxiv·Feb 8, 2023
- Epidermal Growth Factor Receptor Inhibition Prevents Caveolin-1-dependent Calcifying Extracellular Vesicle Biogenesis
A. B. Nik, H. H. Ng, … J. D. Hutcheson·bioRxiv·Nov 8, 2021